{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:06:32Z","timestamp":1793649992844,"version":"4.5.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40257-023-00778-4","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:02:07Z","timestamp":1682611327000},"page":"541-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":false,"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesbah","family":"Talukder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"issue":"11","key":"778_CR1","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1001\/jamaneurol.2022.3491","volume":"79","author":"BJ Billioux","year":"2022","unstructured":"Billioux BJ, Mbaya OT, Sejvar J, Nath A. Neurologic complications of smallpox and monkeypox: a review. JAMA Neurol. 2022;79(11):1180\u20136.","journal-title":"JAMA Neurol"},{"issue":"7","key":"778_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/jama.2022.12513","volume":"328","author":"JB Nuzzo","year":"2022","unstructured":"Nuzzo JB, Borio LL, Gostin LO. The WHO declaration of monkeypox as a global public health emergency. JAMA. 2022;328(7):615\u20137.","journal-title":"JAMA"},{"key":"778_CR3","unstructured":"WHO recommends new name for monkeypox disease. 2022. https:\/\/www.who.int\/news\/item\/28-11-2022-who-recommends-new-name-for-monkeypox-disease#:~:text=Following%20a%20series%20of%20consultations,as%20a%20synonym%20for%20monkeypox. Accessed 14 Dec 2022."},{"issue":"2","key":"778_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jama.2022.10802","volume":"328","author":"J Guarner","year":"2022","unstructured":"Guarner J, Del Rio C, Malani PN. Monkeypox in 2022-what clinicians need to know. JAMA. 2022;328(2):139\u201340.","journal-title":"JAMA"},{"issue":"5","key":"778_CR5","first-page":"593","volume":"46","author":"ID Ladnyj","year":"1972","unstructured":"Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46(5):593\u20137.","journal-title":"Bull World Health Organ"},{"key":"778_CR6","unstructured":"2022 mpox (monkeypox) outbreak: global trends (World Health Organization). 2022. https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/. Accessed 25 Mar 2023."},{"issue":"5","key":"778_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jaad.2022.07.007","volume":"87","author":"JS Bryer","year":"2022","unstructured":"Bryer JS, Freeman EE, Rosenbach M. Monkeypox emerges on a global scale: a historical review and dermatological primer. J Am Acad Dermatol. 2022;87(5):1069\u201374.","journal-title":"J Am Acad Dermatol"},{"key":"778_CR8","unstructured":"World Health Organization. Mpox (monkeypox): experts give virus variants new names. 2022. https:\/\/www.who.int\/news\/item\/12-08-2022-monkeypox--experts-give-virus-variants-new-names. Accessed 15 Sept 2022."},{"issue":"10","key":"778_CR9","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1099\/vir.0.81215-0","volume":"86","author":"AM Likos","year":"2005","unstructured":"Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, et al. A tale of two clades: monkeypox viruses. J Gen Virol. 2005;86(10):2661\u201372.","journal-title":"J Gen Virol"},{"key":"778_CR10","unstructured":"Centers for Disease Control and Prevention. Are there different types of mpox (monkeypox)? 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/about\/faq.html. Accessed 15 Sept 2022."},{"issue":"8","key":"778_CR11","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","volume":"28","author":"J Isidro","year":"2022","unstructured":"Isidro J, Borges V, Pinto M, Sobral D, Santos JD, Nunes A, et al. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat Med. 2022;28(8):1569\u201372.","journal-title":"Nat Med"},{"issue":"12","key":"778_CR12","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1086\/498155","volume":"41","author":"RA Weinstein","year":"2005","unstructured":"Weinstein RA, Nalca A, Rimoin AW, Bavari S, Whitehouse CA. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis. 2005;41(12):1765\u201371.","journal-title":"Clin Infect Dis"},{"key":"778_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40506-021-00257-6","volume":"14","author":"AH Barnes","year":"2022","unstructured":"Barnes AH, Smith C, Dash A, Shishido AA. Mpox: special considerations in the immunocompromised host. Curr Treat Opt Infect Dis. 2022;14:1\u201324.","journal-title":"Curr Treat Opt Infect Dis"},{"key":"778_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ajem.2023.01.007","volume":"65","author":"B Long","year":"2023","unstructured":"Long B, Liang SY, Carius BM, Chavez S, Gottlieb M, Koyfman A, et al. Mimics of Mpox: considerations for the emergency medicine clinician. Am J Emerg Med. 2023;65:172\u20138.","journal-title":"Am J Emerg Med"},{"key":"778_CR15","unstructured":"Schuster-Bruce C, Gal S. How monkeypox symptoms compare to smallpox and chickenpox. 2022. https:\/\/www.insider.com\/monkeypox-smallpox-chickenpox-rash-symptoms-chart-virus-outbreak-2022-5. Accessed 15 Aug 2022."},{"key":"778_CR16","unstructured":"Hagen A. Monkeypox: when to get tested and what to do if exposed. 2022. https:\/\/asm.org\/Articles\/2022\/August\/Monkeypox-When-to-Get-Tested-and-What-to-Do-if-Exp. Accessed 18 Aug 2022."},{"key":"778_CR17","unstructured":"Centers for Disease Control and Prevention. Clinical recognition: key characteristics for identifying mpox. 2023. https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/clinical-recognition.html. Accessed 7 Mar 2023."},{"issue":"5","key":"778_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/bjd.21790","volume":"187","author":"A Catal\u00e0","year":"2022","unstructured":"Catal\u00e0 A, Clavo-Escribano P, Riera-Monroig J, Mart\u00edn-Ezquerra G, Fernandez-Gonzalez P, Revelles-Pe\u00f1as L, et al. Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases. Br J Dermatol. 2022;187(5):765\u201372.","journal-title":"Br J Dermatol"},{"issue":"3","key":"778_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/cid\/ciac737","volume":"76","author":"M Yakubovsky","year":"2023","unstructured":"Yakubovsky M, Shasha D, Reich S, Tau L, Friedel N, Halutz O, et al. Mpox presenting as proctitis in men who have sex with men. Clin Infect Dis. 2023;76(3):528\u201330.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"778_CR20","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1086\/498115","volume":"41","author":"GD Huhn","year":"2005","unstructured":"Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41(12):1742\u201351.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"778_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries\u2014April\u2013June 2022. N Engl J Med. 2022;387(8):679\u201391.","journal-title":"N Engl J Med"},{"issue":"9","key":"778_CR22","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S1473-3099(22)00411-X","volume":"22","author":"N Girometti","year":"2022","unstructured":"Girometti N, Byrne R, Bracchi M, Heskin J, McOwan A, Tittle V, et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. Lancet Infect Dis. 2022;22(9):1321\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"778_CR23","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/bjd.21834","volume":"187","author":"J Griffiths-Acha","year":"2022","unstructured":"Griffiths-Acha J, Vela-Ganuza M, Sarr\u00f3-Fuente C, L\u00f3pez-Estebaranz JL. Monkeypox: a new differential diagnosis when addressing genital ulcer disease. Br J Dermatol. 2022;187(6):1050\u20132.","journal-title":"Br J Dermatol"},{"issue":"10353","key":"778_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","volume":"400","author":"EJ Tar\u00edn-Vicente","year":"2022","unstructured":"Tar\u00edn-Vicente EJ, Alemany A, Agud-Dios M, Ubals M, Su\u00f1er C, Ant\u00f3n A, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022;400(10353):661\u20139.","journal-title":"Lancet"},{"key":"778_CR25","unstructured":"World Health Organization. Laboratory testing for the monkeypox virus: interim guidance. 2022. https:\/\/www.who.int\/publications\/i\/item\/WHO-MPX-laboratory-2022.1. Accessed 27 Sept 2022."},{"key":"778_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijid.2022.08.024","volume":"123","author":"D de Sousa","year":"2022","unstructured":"de Sousa D, Frade J, Patroc\u00ednio J, Borges-Costa J, Filipe P. Monkeypox infection and bacterial cellulitis: a complication to look for. Int J Infect Dis. 2022;123:180\u20132.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"778_CR27","first-page":"509","volume":"35","author":"MC Mart\u00edn-Delgado","year":"2022","unstructured":"Mart\u00edn-Delgado MC, Martin Sanchez F, Martinez-Selles M. Monkeypox in humans: a new outbreak. Rev Esp Quimioter. 2022;35(6):509\u201318.","journal-title":"Rev Esp Quimioter"},{"key":"778_CR28","unstructured":"Centers for Disease Control and Prevention. How it spreads. 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/if-sick\/transmission.html. Accessed 28 Sept 2022."},{"issue":"28","key":"778_CR29","doi-asserted-by":"publisher","first-page":"2200503","DOI":"10.2807\/1560-7917.ES.2022.27.28.2200503","volume":"27","author":"A Peir\u00f3-Mestres","year":"2022","unstructured":"Peir\u00f3-Mestres A, Fuertes I, Camprub\u00ed-Ferrer D, Marcos M, Vilella A, Navarro M, et al. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022. Euro Surveill. 2022;27(28):2200503.","journal-title":"Euro Surveill"},{"key":"778_CR30","unstructured":"World Health Organization. Mpox (monkeypox) 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/monkeypox. Accessed 28 Sept 2022."},{"issue":"1","key":"778_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/tropicalmed1010008","volume":"1","author":"K Brown","year":"2016","unstructured":"Brown K, Leggat PA. Human monkeypox: current state of knowledge and implications for the future. Trop Med Infect Dis. 2016;1(1):8.","journal-title":"Trop Med Infect Dis."},{"issue":"379","key":"778_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-073153","volume":"2","author":"T Ward","year":"2022","unstructured":"Ward T, Christie R, Paton RS, Cumming F, Overton CE. Transmission dynamics of monkeypox in the United Kingdom: contact tracing study. BMJ. 2022;2(379): e073153.","journal-title":"BMJ"},{"issue":"4","key":"778_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1473-3099(22)00794-0","volume":"23","author":"C Su\u00f1er","year":"2023","unstructured":"Su\u00f1er C, Ubals M, Tar\u00edn-Vicente EJ, Mendoza A, Alemany A, Hern\u00e1ndez-Rodr\u00edguez \u00c1, et al. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain. Lancet Infect Dis. 2023;23(4):445\u201353.","journal-title":"Lancet Infect Dis"},{"key":"778_CR34","unstructured":"Government of Canada. Mpox (monkeypox): how it spreads, prevention and risks. 2022. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/monkeypox\/risks.html. Accessed 25 Aug 2022."},{"key":"778_CR35","unstructured":"Centers for Disease Control and Prevention. Impact of monkeypox outbreak on select behaviors. 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/amis-select-behaviors.html#:~:text=In%20an%20online%20survey%20of,encounters%2C%20and%2050%25%20reported%20reducing. Accessed 19 Oct 2022."},{"key":"778_CR36","unstructured":"Centers for Disease Control and Prevention. Mpox (monkeypox) and smallpox vaccine guidance. 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/smallpox-vaccine.html. Accessed 26 Sept 2022."},{"issue":"37","key":"778_CR37","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1073\/pnas.1005769107","volume":"107","author":"AW Rimoin","year":"2010","unstructured":"Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA. 2010;107(37):16262\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"778_CR38","unstructured":"US FDA. ACAM2000: highlights of prescribing information. 2018. https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/acam2000. Accessed 30 Aug 2022."},{"key":"778_CR39","unstructured":"Drugs.com. Jynneos prescribing information. 2023. https:\/\/www.drugs.com\/pro\/jynneos.html. Accessed 6 Mar 2023."},{"key":"778_CR40","unstructured":"US FDA. JYNNEOS :highlights of prescribing information. 2022. https:\/\/www.fda.gov\/vaccines-blood-biologics\/jynneos. Accessed 30 Aug 2022."},{"issue":"3","key":"778_CR41","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","volume":"29","author":"YW Sagy","year":"2023","unstructured":"Sagy YW, Zucker R, Hammerman A, Markovits H, Arieh NG, Ahmad WA, et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nat Med. 2023;29(3):748\u201352.","journal-title":"Nat Med"},{"key":"778_CR42","unstructured":"US FDA. Vaccine adverse event reporting system (VAERS). 2022. http:\/\/wonder.cdc.gov\/vaers.html. Accessed 30 Oct 2022."},{"key":"778_CR43","unstructured":"Centers for Disease Control and Prevention. Vaccination. 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/interim-considerations\/overview.html#:~:text=Currently%2C%20CDC%20is%20not%20recommending,monkeypox%20for%20the%20general%20public. Accessed 19 Oct 2022."},{"issue":"9","key":"778_CR44","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","volume":"82","author":"JG Rizk","year":"2022","unstructured":"Rizk JG, Lippi G, Henry BM, Forthal DN, Rizk Y. Prevention and treatment of monkeypox. Drugs. 2022;82(9):957\u201363.","journal-title":"Drugs"},{"key":"778_CR45","unstructured":"Centers for Disease Control and Prevention. Monitoring and risk assessment for persons exposed in the community. 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/monitoring.html. Accessed 21 Sept 2022."},{"key":"778_CR46","unstructured":"Centers for Disease Control and Prevention. Interim clinical guidance for the treatment of mpox (monkeypox). 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/treatment.html. Accessed 22 Sept 2022."},{"key":"778_CR47","unstructured":"European Centers for Disease Prevention and Control. Factsheet for health professionals on mpox (monkeypox). 2022. https:\/\/www.ecdc.europa.eu\/en\/all-topics-z\/monkeypox\/factsheet-health-professionals#:~:text=The%20pathogen,%2Drelated%20poxviruses%20%5B2%5D. Accessed 28 Aug 2022."},{"key":"778_CR48","unstructured":"European Medicines Agency. Vistide, INN (cidofovir). 2007. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vistide-epar-product-information_en.pdf. Accessed 30 Aug 2022."},{"key":"778_CR49","unstructured":"Centre for Infectious Disease Research and Policy. Smallpox: agent and pathogenesis. 2014. https:\/\/www.cidrap.umn.edu\/infectious-disease-topics\/smallpox#overview. Accessed 28 Aug 2022."},{"key":"778_CR50","unstructured":"US FDA. CNJ-016, Vaccinia Immune Globulin Intravenous (Human), sterile solution; highlights of prescribing information. 2010. https:\/\/www.fda.gov\/media\/78174\/download. Accessed 22 Sept 2022."},{"key":"778_CR51","unstructured":"US FDA. Highlights of prescribing information, TPOXX\u00ae (tecovirimat) capsules, for oral use and TPOXX\u00ae (tecovirimat) injection, for IV use. 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214518s000lbl.pdf. Accessed 30 Aug 2022."},{"issue":"4","key":"778_CR52","doi-asserted-by":"publisher","first-page":"e00752","DOI":"10.1128\/genomeA.00752-15","volume":"3","author":"F Garc\u00e9s-Ayala","year":"2015","unstructured":"Garc\u00e9s-Ayala F, Rodr\u00edguez-Castillo A, Ortiz-Alc\u00e1ntara JM, Gonzalez-Dur\u00e1n E, Segura-Candelas JM, P\u00e9rez-Ag\u00fceros SI, et al. Full-genome sequence of a novel varicella-zoster virus clade isolated in Mexico. Genome Announc. 2015;3(4):e00752-e815.","journal-title":"Genome Announc"},{"key":"778_CR53","unstructured":"Hamilton K, Regier L, Jensen B. Anti-infectives for common infections: overview & management (RxFiles). 2021. http:\/\/www.RxFiles.ca. Accessed 18 Dec 2021."},{"key":"778_CR54","unstructured":"Centers for Disease Control and Prevention. Prevention and treatment of chickenpox. 2021. https:\/\/www.cdc.gov\/chickenpox\/about\/prevention-treatment.html. Accessed 25 Aug 2022."},{"key":"778_CR55","unstructured":"Chickenpox (NHS inform). 2021. https:\/\/www.nhsinform.scot\/illnesses-and-conditions\/infections-and-poisoning\/chickenpox#treating-chickenpox. Accessed 25 Aug 2022."},{"key":"778_CR56","unstructured":"Mpox management approach: BMJ best practice. 2022. https:\/\/bestpractice.bmj.com\/topics\/en-us\/1611\/management-approach. Accessed 8 Mar 2023."},{"key":"778_CR57","unstructured":"Mpox selfcare (CDC). 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/pdf\/SelfCare-InfoSheet.pdf. Accessed 12 Dec 2022."},{"key":"778_CR58","unstructured":"US FDA. Highlights of prescribing information, TEMBEXA (brincidofovir) tablets, for oral use and TEMBEXA (brincidofovir) oral suspension. 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/214460s000,214461s000lbl.pdf. Accessed 30 Aug 2022."},{"issue":"3","key":"778_CR59","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","volume":"19","author":"AT Russo","year":"2021","unstructured":"Russo AT, Grosenbach DW, Chinsangaram J, Honeychurch KM, Long PG, Lovejoy C, et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther. 2021;19(3):331\u201344.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"778_CR60","volume-title":"Pharmacology examination & board review","author":"AJ Trevor","year":"2010","unstructured":"Trevor AJ, Katzung BG, Masters SB, Kruidering-Hall M. Pharmacology examination & board review. New York: McGraw-Hill Medical New; 2010."},{"issue":"1","key":"778_CR61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00710-4","volume":"7","author":"Y Huang","year":"2022","unstructured":"Huang Y, Mu L, Wang W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduct Target Ther. 2022;7(1):1\u201322.","journal-title":"Signal Transduct Target Ther"},{"key":"778_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.10.043","author":"TG Sobral-Costas","year":"2022","unstructured":"Sobral-Costas TG, Escudero-Tornero R, Servera-Negre G, Bernardino JI, Arroyo AG, D\u00edaz-Men\u00e9ndez M, et al. Human monkeypox outbreak: epidemiological data and therapeutic potential of topical cidofovir in a prospective cohort study. J Am Acad Dermatol doi. 2022. https:\/\/doi.org\/10.1016\/j.jaad.2022.10.043. (Epub 29 Nov 2022).","journal-title":"J Am Acad Dermatol. doi."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00778-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-023-00778-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-023-00778-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:11:02Z","timestamp":1744715462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-023-00778-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s40257-023-00778-4","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"27 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to assist in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Aditya K. Gupta, Mesbah Talukder, Ted Rosen, and Vincent Piguet have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that human ethics approval was not required for this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Manuscript conception was undertaken by AKG, and the work was drafted by MT, TR, and VP and substantively revised by AKG, MT, TR and VP.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}